Investigación / Grupos de investigación

Grupo  402

Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Publicaciones (398)

  • Tural, C; Sola, R; Alvarez, NP; Molto, J; Sanchez, M; Zamora, AM; Ornelas, A; Laguno, M; Gonzalez, J; von Wichmann, MA; Tellez, MJ; Paredes, R; Clotet, B.

    Effect of an induction period of pegylated interferon-alpha 2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

    ANTIVIRAL THERAPY. 2011; 16(6): 833-841 Nº de citas: 1 [doi:10.3851/IMP1837]

  • Hernán MA; Álvaro-Meca A; Calvo-Alcántara MJ; Navarro Gómez ML; Ramos JT; Estévez JC; Basanta M; Ruiz S; Matáix ÁL; Cosano L; Silva AP; Salas P; Arribas JR; Molero JM; Berenguer J.

    Effectiveness and Safety of COVID-19 mRNA Vaccines in Children 6-17 Years Old: A Population-Based Study in Madrid.

    PEDIATRIC INFECTIOUS DISEASE JOURNAL. ; : [doi:10.1097/INF.0000000000005109]